Goldman Sachs’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-183,678
| Closed | -$3.26M | – | 5927 |
|
|
2018
Q3 | $3.26M | Buy |
183,678
+21,006
| +13% | +$361K | ﹤0.01% | 3273 |
|
|
2018
Q2 | $2.25M | Sell |
162,672
-202,360
| -55% | -$2.4M | ﹤0.01% | 3555 |
|
|
2018
Q1 | $3.32M | Buy |
365,032
+191,273
| +110% | +$1.06M | ﹤0.01% | 3218 |
|
|
2017
Q4 | $744K | Buy |
173,759
+162,498
| +1,443% | +$774K | ﹤0.01% | 4526 |
|
|
2017
Q3 | $16K | Sell |
11,261
-419,733
| -97% | -$585K | ﹤0.01% | 6462 |
|
|
2017
Q2 | $646K | Buy |
430,994
+393,975
| +1,064% | +$846K | ﹤0.01% | 4863 |
|
|
2017
Q1 | $95K | Sell |
37,019
-46,421
| -56% | -$107K | ﹤0.01% | 6086 |
|
|
2016
Q4 | $213K | Buy |
83,440
+31,696
| +61% | +$91K | ﹤0.01% | 5729 |
|
|
2016
Q3 | $160K | Sell |
51,744
-24,091
| -32% | -$75.1K | ﹤0.01% | 5968 |
|
|
2016
Q2 | $243K | Sell |
75,835
-53,108
| -41% | -$195K | ﹤0.01% | 5532 |
|
|
2016
Q1 | $400K | Buy |
128,943
+112,302
| +675% | +$367K | ﹤0.01% | 4977 |
|
|
2015
Q4 | $67K | Buy |
16,641
+3,401
| +26% | +$15.7K | ﹤0.01% | 6405 |
|
|
2015
Q3 | $61K | Sell |
13,240
-13,313
| -50% | -$69.7K | ﹤0.01% | 6719 |
|
|
2015
Q2 | $138K | Buy |
26,553
+1,420
| +6% | +$8.52K | ﹤0.01% | 6433 |
|
|
2015
Q1 | $158K | Buy |
+25,133
| New | +$145K | ﹤0.01% | 6168 |
|
|
2014
Q4 | – | Sell |
-14,737
| Closed | -$90K | – | 7432 |
|
|
2014
Q3 | $90K | Sell |
14,737
-86,147
| -85% | -$588K | ﹤0.01% | 6627 |
|
|
2014
Q2 | $665K | Buy |
100,884
+88,077
| +688% | +$992K | ﹤0.01% | 5070 |
|
|
2014
Q1 | $305K | Sell |
12,807
-14,732
| -53% | -$214K | ﹤0.01% | 5724 |
|
|
2013
Q4 | $294K | Buy |
27,539
+3,323
| +14% | +$36.7K | ﹤0.01% | 5712 |
|
|
2013
Q3 | $323K | Buy |
24,216
+10,487
| +76% | +$166K | ﹤0.01% | 5513 |
|
|
2013
Q2 | $180K | Buy |
+13,729
| New | +$185K | ﹤0.01% | 5654 |
|